TreeWAS – Variant ID: rs11149058

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z88.5 Personal history of allergy to narcotic agent	0.000	0.971	0.029
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.976	0.024
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.010	0.990	0.000
H35.3 Degeneration of macula and posterior pole	0.008	0.992	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.008	0.992	0.000
H20.9 Iridocyclitis, unspecified	0.000	0.993	0.007
W19.4 Street and highway	0.000	0.993	0.007
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.007	0.993	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.007	0.993	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.006	0.994	0.000
H18.8 Other specified disorders of cornea	0.000	0.994	0.006
K65.0 Acute peritonitis	0.000	0.994	0.006
L91.0 Keloid scar	0.006	0.994	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.006	0.994	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.006	0.994	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.006	0.994	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.006	0.994	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.006	0.994	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.005	0.994	0.000
H18 Other disorders of cornea	0.000	0.994	0.006
Y42.5 Other oestrogens and progestogens	0.006	0.994	0.000
H20 Iridocyclitis	0.000	0.995	0.005
Y40.0 Penicillins	0.005	0.995	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.995	0.005
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.995	0.005
H20.0 Acute and subacute iridocyclitis	0.000	0.995	0.005
N81.6 Rectocele	0.000	0.995	0.005
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
H18.1 Bullous keratopathy	0.000	0.995	0.005
Y42.7 Androgens and anabolic congeners	0.005	0.995	0.000
H18.9 Disorder of cornea, unspecified	0.000	0.995	0.005
H18.6 Keratoconus	0.000	0.995	0.005
H00.0 Hordeolum and other deep inflammation of eyelid	0.000	0.995	0.005
Y40 Systemic antibiotics	0.004	0.995	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.996	0.004
H18.7 Other corneal deformities	0.000	0.996	0.004
H20.1 Chronic iridocyclitis	0.000	0.996	0.004
R40.2 Coma, unspecified	0.000	0.996	0.004
H18.4 Corneal degeneration	0.000	0.996	0.004
Y40.1 Cefalosporins and other -lactam antibiotics	0.004	0.996	0.000
H18.0 Corneal pigmentations and deposits	0.000	0.996	0.004
H20.2 Lens-induced iridocyclitis	0.000	0.996	0.004
H18.3 Changes in corneal membranes	0.000	0.996	0.004
N81.9 Female genital prolapse, unspecified	0.000	0.996	0.004
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.000	0.996	0.004
K81.9 Cholecystitis, unspecified	0.000	0.996	0.004
S42.30 Fracture of shaft of humerus (closed)	0.004	0.996	0.000
H18.2 Other corneal oedema	0.000	0.996	0.004
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
M05 Seropositive rheumatoid arthritis	0.004	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y46.4 Iminostilbenes	0.004	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
I78.1 Naevus, nonneoplastic	0.000	0.996	0.004
Y46.6 Other and unspecified antiepileptics	0.004	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.996	0.000
Y40.3 Macrolides	0.003	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
Y40.6 Rifamycins	0.003	0.996	0.000
Y40.4 Tetracyclines	0.003	0.996	0.000
Y40.2 Chloramphenicol group	0.003	0.996	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.997	0.003
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
J39.8 Other specified diseases of upper respiratory tract	0.003	0.997	0.000
Z57.2 Occupational exposure to dust	0.003	0.997	0.000
W19 Unspecified fall	0.000	0.997	0.003
H16 Keratitis	0.000	0.997	0.003
E21.0 Primary hyperparathyroidism	0.000	0.997	0.003
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.003	0.997	0.000
M54.12 Radiculopathy (Cervical region)	0.003	0.997	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
M05.2 Rheumatoid vasculitis	0.003	0.997	0.000
N81.1 Cystocele	0.000	0.997	0.003
W19.2 School, other institution and public administrative area	0.000	0.997	0.003
Z93.2 Ileostomy status	0.000	0.997	0.003
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
M05.8 Other seropositive rheumatoid arthritis	0.003	0.997	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.003	0.997	0.000
M05.1 Rheumatoid lung disease	0.003	0.997	0.000
M05.0 Felty's syndrome	0.003	0.997	0.000
W19.3 Sports and athletics area	0.000	0.997	0.003
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.997	0.003
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
H17 Corneal scars and opacities	0.000	0.997	0.003
N81 Female genital prolapse	0.000	0.997	0.003
Y54.5 Other diuretics	0.003	0.997	0.000
Q23.0 Congenital stenosis of aortic valve	0.000	0.997	0.003
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.000	0.997	0.003
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.000	0.997	0.003
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Q23 Congenital malformations of aortic and mitral valves	0.000	0.997	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
C18.6 Descending colon	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.997	0.003
Y59.3 Immunoglobulin	0.003	0.997	0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.000	0.997	0.003
H16.0 Corneal ulcer	0.000	0.997	0.003
W19.6 Industrial and construction area	0.000	0.997	0.003
W19.1 Residential institution	0.000	0.997	0.003
H16.9 Keratitis, unspecified	0.000	0.997	0.003
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.997	0.003
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
M05.20 Rheumatoid vasculitis (Multiple sites)	0.002	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.997	0.000
Y54.0 Mineralocorticoids	0.002	0.997	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.997	0.003
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
R40.0 Somnolence	0.000	0.997	0.003
W19.8 Other specified place	0.000	0.997	0.002
W19.5 Trade and service area	0.000	0.997	0.002
W19.0 Home	0.000	0.997	0.002
W19.7 Farm	0.000	0.997	0.002
H16.8 Other keratitis	0.000	0.997	0.002
H16.4 Corneal neovascularisation	0.000	0.997	0.002
H16.3 Interstitial and deep keratitis	0.000	0.997	0.002
Y46.2 Hydantoin derivatives	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.997	0.000
H15 Disorders of sclera	0.000	0.997	0.002
N81.0 Female urethrocele	0.000	0.997	0.003
S00.9 Superficial injury of head, part unspecified	0.000	0.997	0.003
Y56.3 Emollients, demulcents and protectants	0.002	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.997	0.000
Y59.2 Protozoal vaccines	0.002	0.997	0.000
Y59.1 Rickettsial vaccines	0.002	0.997	0.000
Y59.0 Viral vaccines	0.002	0.997	0.000
I24 Other acute ischaemic heart diseases	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.002	0.997	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.997	0.003
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.000	0.997	0.002
H16.2 Keratoconjunctivitis	0.000	0.997	0.002
H17.8 Other corneal scars and opacities	0.000	0.997	0.002
Y41.0 Sulphonamides	0.002	0.997	0.000
Y56.9 Topical agent, unspecified	0.002	0.997	0.000
Y56.8 Other topical agents	0.002	0.997	0.000
Y56.7 Dental drugs, topically applied	0.002	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
Y56.2 Local astringents and local detergents	0.002	0.997	0.000
Y56.1 Antipruritics	0.002	0.997	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.002	0.997	0.000
M05.28 Rheumatoid vasculitis (Other)	0.002	0.997	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.002	0.997	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.002	0.997	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.002	0.997	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.002	0.997	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.002	0.997	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.002	0.997	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.002	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.000	0.998	0.002
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.000	0.998	0.002
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.000	0.998	0.002
H20.8 Other iridocyclitis	0.001	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
N81.4 Uterovaginal prolapse, unspecified	0.000	0.998	0.002
Y41.5 Antiviral drugs	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.000	0.998	0.002
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
M05.09 Felty's syndrome (Site unspecified)	0.002	0.998	0.000
M05.08 Felty's syndrome (Other)	0.002	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.002	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.002	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.002	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.002	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.002	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.002	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.002	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.002	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.002	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.002	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.002	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.002	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.002	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.002	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.002	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.002	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.002	0.998	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.002	0.998	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.002	0.998	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.002	0.998	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.002	0.998	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.002	0.998	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.002	0.998	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.002	0.998	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.002	0.998	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.002	0.998	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.002	0.998	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.002	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.002	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.002	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.998	0.002
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
R40 Somnolence, stupor and coma	0.000	0.998	0.002
H17.1 Other central corneal opacity	0.000	0.998	0.002
H17.0 Adherent leukoma	0.000	0.998	0.002
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.998	0.002
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.000	0.998	0.002
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.000	0.998	0.002
N41.0 Acute prostatitis	0.000	0.998	0.002
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.002	0.998	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.000	0.998	0.002
Q23.8 Other congenital malformations of aortic and mitral valves	0.000	0.998	0.002
Q23.4 Hypoplastic left heart syndrome	0.000	0.998	0.002
Q23.3 Congenital mitral insufficiency	0.000	0.998	0.002
Q23.2 Congenital mitral stenosis	0.000	0.998	0.002
R22.1 Localised swelling, mass and lump, neck	0.000	0.998	0.002
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.000	0.998	0.002
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
M54.1 Radiculopathy	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.000	0.998	0.002
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.000	0.998	0.002
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.000	0.998	0.002
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.000	0.998	0.002
I60 Subarachnoid haemorrhage	0.002	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.000	0.998	0.002
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.002	0.998	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.998	0.002
M54.16 Radiculopathy (Lumbar region)	0.002	0.998	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.000	0.998	0.002
I24.1 Dressler's syndrome	0.000	0.998	0.002
M54.17 Radiculopathy (Lumbosacral region)	0.002	0.998	0.000
Q27.3 Peripheral arteriovenous malformation	0.000	0.998	0.002
H15.1 Episcleritis	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
H15.8 Other disorders of sclera	0.000	0.998	0.002
H15.0 Scleritis	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
M54.14 Radiculopathy (Thoracic region)	0.002	0.998	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.002	0.998	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.002	0.998	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.002	0.998	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.000	0.998	0.002
H17.9 Corneal scar and opacity, unspecified	0.000	0.998	0.002
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.000	0.998	0.002
E04.9 Non-toxic goitre, unspecified	0.000	0.998	0.002
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.998	0.002
D48.1 Connective and other soft tissue	0.002	0.998	0.000
M54.15 Radiculopathy (Thoracolumbar region)	0.002	0.998	0.000
M54.13 Radiculopathy (Cervicothoracic region)	0.002	0.998	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.002	0.998	0.000
H43.8 Other disorders of vitreous body	0.000	0.998	0.002
S42.3 Fracture of shaft of humerus	0.002	0.998	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.000	0.998	0.002
L92 Granulomatous disorders of skin and subcutaneous tissue	0.000	0.998	0.002
M25.06 Haemarthrosis (Lower leg)	0.000	0.998	0.002
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.002	0.998	0.000
N05.8 Other	0.002	0.998	0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.001	0.998	0.000
X41.9 Unspecified place	0.002	0.998	0.000
X47.9 Unspecified place	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.001	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.000	0.998	0.002
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.000	0.998	0.002
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.001	0.998	0.000
Y57.4 Pharmaceutical excipients	0.001	0.998	0.000
Y57.3 Alcohol deterrents	0.001	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.998	0.000
Y57.1 Lipotropic drugs	0.001	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.998	0.000
N05 Unspecified nephritic syndrome	0.002	0.998	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.001
V43.9 Unspecified car occupant injured in traffic accident	0.002	0.998	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
O69.1 Labour and delivery complicated by cord around neck, with compression	0.000	0.998	0.002
X47.0 Home	0.002	0.998	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.002
L92.0 Granuloma annulare	0.000	0.998	0.002
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.002	0.998	0.000
E10.4 With neurological complications	0.000	0.998	0.002
H43.9 Disorder of vitreous body, unspecified	0.000	0.998	0.002
M54.19 Radiculopathy (Site unspecified)	0.001	0.998	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.000	0.998	0.001
H21.3 Cyst of iris, ciliary body and anterior chamber	0.000	0.998	0.001
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.000	0.998	0.001
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.000	0.998	0.001
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S42.31 Fracture of shaft of humerus (open)	0.001	0.998	0.000
N05.9 Unspecified	0.002	0.998	0.000
R40.1 Stupor	0.000	0.998	0.001
Y49.5 Other antipsychotics and neuroleptics	0.001	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.998	0.001
H21.0 Hyphaema	0.000	0.998	0.001
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
Q20-Q28 Congenital malformations of the circulatory system	0.000	0.998	0.002
D68.5 Primary Thrombophilia	0.002	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.998	0.001
M85.8 Other specified disorders of bone density and structure	0.002	0.998	0.000
T00.8 Superficial injuries involving other combinations of body regions	0.001	0.998	0.000
E28.2 Polycystic ovarian syndrome	0.001	0.998	0.000
H21.4 Pupillary membranes	0.000	0.998	0.001
N05.7 Diffuse crescentic glomerulonephritis	0.001	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.998	0.000
Q27.4 Congenital phlebectasia	0.000	0.998	0.001
Q27.2 Other congenital malformations of renal artery	0.000	0.998	0.001
Q27.1 Congenital renal artery stenosis	0.000	0.998	0.001
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.000	0.998	0.001
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
M85.99 Disorder of bone density and structure, unspecified (Site unspecified)	0.001	0.999	0.000
D26.1 Corpus uteri	0.001	0.999	0.000
N05.6 Dense deposit disease	0.001	0.999	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.999	0.000
N05.0 Minor glomerular abnormality	0.001	0.999	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.000	0.999	0.001
Q27.8 Other specified congenital malformations of peripheral vascular system	0.000	0.999	0.001
M41.99 Scoliosis, unspecified (Site unspecified)	0.001	0.999	0.000
N81.8 Other female genital prolapse	0.000	0.999	0.001
N81.5 Vaginal enterocele	0.000	0.999	0.001
W02.9 Unspecified place	0.001	0.999	0.000
X47.8 Other specified place	0.001	0.999	0.000
X47.7 Farm	0.001	0.999	0.000
X47.6 Industrial and construction area	0.001	0.999	0.000
X47.5 Trade and service area	0.001	0.999	0.000
X47.4 Street and highway	0.001	0.999	0.000
X47.3 Sports and athletics area	0.001	0.999	0.000
X47.2 School, other institution and public administrative area	0.001	0.999	0.000
X47.1 Residential institution	0.001	0.999	0.000
H00 Hordeolum and chalazion	0.000	0.999	0.001
M85.83 Other specified disorders of bone density and structure (Forearm)	0.001	0.999	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.001	0.999	0.000
N05.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.000	0.999	0.001
Y44.2 Anticoagulants	0.001	0.999	0.000
K65 Peritonitis	0.000	0.999	0.001
X40-X49 Accidental poisoning by and exposure to noxious substances	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.000	0.999	0.001
E21.2 Other hyperparathyroidism	0.000	0.999	0.001
H21.2 Degeneration of iris and ciliary body	0.000	0.999	0.001
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.999	0.001
O80.8 Other single spontaneous delivery	0.001	0.999	0.000
H43 Disorders of vitreous body	0.000	0.999	0.001
M19.96 Arthrosis, unspecified-Lower leg	0.001	0.999	0.000
M85.80 Other specified disorders of bone density and structure (Multiple sites)	0.001	0.999	0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.000	0.999	0.001
Q24 Other congenital malformations of heart	0.000	0.999	0.001
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.001	0.999	0.000
X41.0 Home	0.001	0.999	0.000
X41.8 Other specified place	0.001	0.999	0.000
X41.7 Farm	0.001	0.999	0.000
X41.6 Industrial and construction area	0.001	0.999	0.000
X41.5 Trade and service area	0.001	0.999	0.000
X41.4 Street and highway	0.001	0.999	0.000
X41.3 Sports and athletics area	0.001	0.999	0.000
X41.2 School, other institution and public administrative area	0.001	0.999	0.000
X41.1 Residential institution	0.001	0.999	0.000
Q25 Congenital malformations of great arteries	0.000	0.999	0.001
E21.3 Hyperparathyroidism, unspecified	0.000	0.999	0.001
G82.2 Paraplegia, unspecified	0.001	0.999	0.000
J39.0 Retropharyngeal and parapharyngeal abscess	0.001	0.999	0.000
Q26 Congenital malformations of great veins	0.000	0.999	0.001
Q20 Congenital malformations of cardiac chambers and connexions	0.000	0.999	0.001
M85.84 Other specified disorders of bone density and structure (Hand)	0.001	0.999	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.001	0.999	0.000
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.001	0.999	0.000
M94.88 Other specified disorders of cartilage (Other)	0.001	0.999	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.999	0.001
Q28 Other congenital malformations of circulatory system	0.000	0.999	0.001
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.001	0.999	0.000
C71.1 Frontal lobe	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations